Related Experiment Video

Updated: Jul 16, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation

T Aleksic1, M Bechtel, D Krndija

  • 1Department of Internal Medicine I, University of Ulm, Ulm, Germany.

Oncogene
|March 21, 2007
PubMed

Insights

The transcription factor CUTL1 promotes tumor cell migration by stabilizing Src protein levels, activating downstream signaling, and reducing Src degradation. This reveals key molecular pathways in CUTL1-driven cancer invasion.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Transforming growth factor beta (TGFbeta) signaling regulates cell migration and invasion.
  • The homeodomain transcription factor CUTL1 is a downstream mediator of TGFbeta.
  • The precise molecular mechanisms by which CUTL1 promotes tumor cell migration and invasion remain unclear.

Purpose of the Study:

  • To identify signaling pathways downstream of CUTL1 responsible for its effects on tumor cell migration.
  • To elucidate the role of CUTL1 in regulating protein levels and activity of key signaling molecules involved in cell motility.
  • To investigate the contribution of the Src pathway to CUTL1-mediated tumor cell migration.

Main Methods:

  • RNA interference (RNAi) to knock down CUTL1 expression.
  • Analysis of tumor cell spreading and motility.
  • Western blotting to assess protein levels of CUTL1, Src, and downstream effectors.
  • Studies using Src knockout cells (SYF) to determine Src dependency.
  • Investigation of proteasome-mediated protein degradation pathways.

Main Results:

  • Knockdown of CUTL1 reduced tumor cell motility and spreading.
  • CUTL1 stabilizes Src protein levels and enhances Src activation.
  • CUTL1 activates downstream signaling molecules including RhoA, Rac1, Cdc42, and ROCK.
  • CUTL1 decreases proteasome-mediated degradation of Src, potentially via C-terminal Src kinase (Csk) upregulation.
  • Src is essential for CUTL1-induced tumor cell migration, as demonstrated in Src knockout cells.

Conclusions:

  • CUTL1 promotes tumor cell migration and invasion by stabilizing and activating the Src pathway.
  • CUTL1 influences Src protein stability, at least partly, by reducing its proteasomal degradation.
  • The findings establish a direct link between the transcription factor CUTL1 and the Src signaling pathway, providing novel insights into the molecular effectors of CUTL1-driven tumor cell invasion.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...